Universitaire Ziekenhuizen KU Leuven: Breast Neoplasms trials

The registry lists 26 Breast Neoplasms studies with Universitaire Ziekenhuizen KU Leuven as lead sponsor. 4 are open to participants now and 3 have results posted.

Early Phase 1 2Phase 2 6Phase 3 2No phase 18(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA TrialNot yet recruitingNCT07676331Phase 2
• Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast CancerRecruitingNCT07373782Phase 2/3
• Who and Why do Patients Report Lymphedema After Breast Cancer Treatment Without an Objective Measurable SwellingRecruitingNCT06324721Not applicable
• Potential Benefits of Radiotherapy in Prone Position for Breast Cancer Patients: a Planning StudyRecruitingNCT01284153
• Effectiveness of a Modern Educational Intervention in Breast Cancer PatientsCompletedNCT03351075Not applicableResults posted
• Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.CompletedNCT03197389Early Phase 1Results posted
• Effectiveness of Fluoroscopy-guided MLD for Treatment of BCRLCompletedNCT02609724Not applicableResults posted
• The Added Value of a Third Supervised Training Session to a Standard 12-week Rehabilitation Program After Breast Cancer: Pilot StudyCompletedNCT05455385Not applicable
• Co'Moon for Supporting Breast Cancer Patients on Adjuvant Endocrine TherapyCompletedNCT05085678Not applicable
• Preventing Taxane-related Peripheral Neuropathy, Pain and Nail Toxicity: A Prospective Self-controlled Trial Comparing Hilotherapy With Frozen Gloves in Early Breast CancerCompletedNCT04659980Not applicable
• Investigating Atezolizumab in Newly Diagnosed ER Positive Breast Cancer Patients According to Their AdipOsityWithdrawnNCT04630210Early Phase 1
• FATLAS: Comprehensive Multi-level Characterization of Systemic and Mammary Adiposity in Breast Cancer Patients.Active, not recruitingNCT04200768Not applicable
• Magnetic Seed Localisation for Nonpalpable Breast LesionsCompletedNCT03988777
• A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With BreastcancerCompletedNCT03956654
• Presentation of First Time Attenders at Lymphedema ClinicsCompletedNCT03687749
• Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related LymphedemaCompletedNCT03210311Not applicable
• Effect of Early Removal of Wound Drains After Mastectomy or Lymph Node DissectionCompletedNCT03104153Not applicable
• Age-related Changes in the Immune System and Their Impact on Elderly Breast CancerCompletedNCT02327572
• Digital 3D Breast Tomosynthesis Versus 2D in Clinical Evaluation of High Risk WomenStatus unknownNCT02209129
• Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer PatientsTerminatedNCT01809171Phase 2/3
• Whole-body MR in Staging Bone and Soft Tissue Metastases in Breast Cancer Patients(MetaMaRBo)Status unknownNCT01291082
• A Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors and TamoxifenCompletedNCT01223833
• Gene Polymorphisms and Gene Products as Biological Markers of Aging and Correlation With Clinical Geriatric Assessment, Tolerance of Chemotherapy and Outcome in Elderly Breast Cancer PatientsCompletedNCT00849758
• Caelyx Adjuvant in Elderly Breast CancerCompletedNCT00284336Phase 2
• SU11248 as Consolidation After Response to Taxanes in Metastatic Breast CancerCompletedNCT00270413Phase 2
• Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast CancerCompletedNCT00256360Phase 2